Okamoto M - Search Results

1

Novel RT-PCR Using Sugar Chain-Immobilized Gold-Nanoparticles Correlates Patients' Symptoms: The Follow-Up Study of COVID-19 Hospitalized Patients.

Kajiya T, Sawayama H, Arima E, Okamoto M, Baba M, Toyama M, Okuya K, Ozawa M, Atsuchi N, Nishi J, Suda Y. Kajiya T, et al. Among authors: okamoto m. Viruses. 2022 Nov 21;14(11):2577. doi: 10.3390/v14112577. Viruses. 2022. PMID: 36423185 Free PMC article.

2

Inhibition of the tax-dependent human T-lymphotropic virus type I replication in persistently infected cells by the fluoroquinolone derivative k-37.

Wang X, Miyake H, Okamoto M, Saito M, Fujisawa J, Tanaka Y, Izumo S, Baba M. Wang X, et al. Among authors: okamoto m. Mol Pharmacol. 2002 Jun;61(6):1359-65. doi: 10.1124/mol.61.6.1359. Mol Pharmacol. 2002. PMID: 12021397

3

Breast cancer resistance protein (BCRP/ABCG2) induces cellular resistance to HIV-1 nucleoside reverse transcriptase inhibitors.

Wang X, Furukawa T, Nitanda T, Okamoto M, Sugimoto Y, Akiyama S, Baba M. Wang X, et al. Among authors: okamoto m. Mol Pharmacol. 2003 Jan;63(1):65-72. doi: 10.1124/mol.63.1.65. Mol Pharmacol. 2003. PMID: 12488537

4

Establishment of an in vitro assay system mimicking human immunodeficiency virus type 1-induced neural cell death and evaluation of inhibitors thereof.

Okamoto M, Wang X, Debyser Z, De Clercq E, Baba M. Okamoto M, et al. J Virol Methods. 2003 Mar;108(2):195-203. doi: 10.1016/s0166-0934(02)00288-4. J Virol Methods. 2003. PMID: 12609687

5

Induction of cellular resistance to nucleoside reverse transcriptase inhibitors by the wild-type breast cancer resistance protein.

Wang X, Nitanda T, Shi M, Okamoto M, Furukawa T, Sugimoto Y, Akiyama S, Baba M. Wang X, et al. Among authors: okamoto m. Biochem Pharmacol. 2004 Oct 1;68(7):1363-70. doi: 10.1016/j.bcp.2004.05.052. Biochem Pharmacol. 2004. PMID: 15345326

6

HIV-1-infected macrophages induce astrogliosis by SDF-1alpha and matrix metalloproteinases.

Okamoto M, Wang X, Baba M. Okamoto M, et al. Biochem Biophys Res Commun. 2005 Nov 4;336(4):1214-20. doi: 10.1016/j.bbrc.2005.08.251. Biochem Biophys Res Commun. 2005. PMID: 16169519

7

Isolation and characterization of human immunodeficiency virus type 1 resistant to the small-molecule CCR5 antagonist TAK-652.

Baba M, Miyake H, Wang X, Okamoto M, Takashima K. Baba M, et al. Among authors: okamoto m. Antimicrob Agents Chemother. 2007 Feb;51(2):707-15. doi: 10.1128/AAC.01079-06. Epub 2006 Nov 20. Antimicrob Agents Chemother. 2007. PMID: 17116673 Free PMC article.

8

Potent and selective inhibition of Tat-dependent HIV-1 replication in chronically infected cells by a novel naphthalene derivative JTK-101.

Wang X, Yamataka K, Okamoto M, Ikeda S, Baba M. Wang X, et al. Among authors: okamoto m. Antivir Chem Chemother. 2007;18(4):201-11. doi: 10.1177/095632020701800404. Antivir Chem Chemother. 2007. PMID: 17907378 Free article.

9

Highly enhanced expression of CD70 on human T-lymphotropic virus type 1-carrying T-cell lines and adult T-cell leukemia cells.

Baba M, Okamoto M, Hamasaki T, Horai S, Wang X, Ito Y, Suda Y, Arima N. Baba M, et al. Among authors: okamoto m. J Virol. 2008 Apr;82(8):3843-52. doi: 10.1128/JVI.02013-07. Epub 2008 Feb 6. J Virol. 2008. PMID: 18256142 Free PMC article.

10

Inhibition of porcine endogenous retrovirus (PERV) replication by HIV-1 gene expression inhibitors.

Shi M, Wang X, Okamoto M, Takao S, Baba M. Shi M, et al. Among authors: okamoto m. Antiviral Res. 2009 Aug;83(2):201-4. doi: 10.1016/j.antiviral.2009.04.011. Epub 2009 May 3. Antiviral Res. 2009. PMID: 19414036

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,809 results

Search Page

Filters